Continued research in this area will undoubtedly deepen our understanding of 14-3-3 proteins’ therapeutic potential, bringing us closer to effective treatments for Alzheimer’s disease and other neurological disorders. Here, YWHAQ is linked to early-onset autosomal dominant Alzheimer disease.